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Summary: The structural information in high-dimensional transposable data allows us to write the data recorded for
each subject in a matrix such that both the rows and the columns correspond to variables of interest. One important
problem is to test the null hypothesis that the mean matrix has a particular structure without ignoring the potential
dependence structure among and/or between the row and column variables. To address this, we develop a simple and
computationally efficient nonparametric testing procedure to assess the hypothesis that, in each predefined subset of
columns (rows), the column (row) mean vector remains constant. In simulation studies, the proposed testing procedure
seems to have good performance and unlike traditional approaches, it is powerful without leading to inflated nominal
sizes. Finally, we illustrate the use of the proposed methodology via two empirical examples from gene expression
microarrays.
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1. Introduction
In some applications, the measurements related to each subject are naturally organized in a
matrix, especially when the rows and columns correspond to two different sets of variables
and dependencies are expected to occur between and/or among them. Allen and Tibshirani
(2010) introduced the term ‘transposable data’ to acknowledge the structural information
and the presence of two-way dependencies in matrix-valued random variables. Examples
of transposable data can be found in spatiotemporal studies (Genton, 2007; Mardia and
Goodall, 1993), in cross-classified multivariate data (Galecki, 1994; Naik and Rao, 2001), in
genetics (Allen and Tibshirani, 2010, 2012; Efron, 2009; Teng and Huang, 2009), in functional
MRI (Allen and Tibshirani, 2010) and in time-series (Carvalho and West, 2007; Lee, Daniels,
and Joo, 2013).
Our work is motivated by biological studies that use microarrays to study gene expression
patterns in multiple tissue samples taken from the same subject (Sottoriva et al., 2013; Zahn
et al., 2007). For each subject, the row variables correspond to genes, the column variables
to tissue samples and the measurements are mRNA gene expression levels. A biologically
important objective is to check whether different subsets of the samples share a common
mean vector of gene expression levels. Application of standard statistical methods, such as
the analysis of variance (ANOVA), is hindered by two factors: (i) the ‘large p, small N ’
setting (the number of genes will typically exceed the number of subjects); and (ii) the high-
dimensional dependence structure (since the genes and the tissue samples are not expected
to be independent of each other).
To introduce these concepts in mathematical terms, suppose that an experimentalist
collects N independent and identically distributed (i.i.d.) transposable r×c random matrices
X1, . . . ,XN . For each subject, there are r row variables and c column variables and the high-
dimensional setting is indicated by letting the sample size (N) be much smaller than the
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number of observations (rc) for a single subject. The goal is to test pre-specified hypotheses
about M = E[Xi], the r × c mean matrix of the transposable data.
To illustrate some difficulties of this task, consider the simple hypothesis
H0 : M = µ1
T
c vs H1 : M 6= µ1Tc , (1)
where µ is an unknown r-variate parameter vector and 1s denotes an s-variate vector of
ones. The null hypothesis suggests that the mean-relationship between the row and column
variables is completely determined by the row variables. In the motivating examples, H0
in (1) is consistent with no genes showing differential expression across the multiple tissue
samples. To the best of our knowledge, no statistical procedure exists to test hypothesis (1)
directly in high-dimensional transposable data unless there are only two dependent column
variables (c = 2). In this case, one approach is to employ the test proposed by Chen and
Qin (2010) for comparing the mean vector of paired high-dimensional random vectors. To
accomplish this, one needs to form the random vector of the difference of the two columns
for each subject and then test the hypothesis of a zero mean vector. Unfortunately, there is
no straightforward way to apply or extend this test when c > 2. In particular, attempts to
do this essentially infer rather than test the mean relationship between the row and column
variables. For example, suppose that M = [µ,−µ,µ,−µ] and consider the following naive
algorithm to test hypothesis (1). First, create two groups of column variables, one based on
the first two columns and the other based on the last two. Second, for each group create N
r-variate random vectors by averaging the appropriate columns in each matrix, and then for
each subject create the r-variate vectors of the difference of the two groups. Thirdly, test
hypothesis (1) using the test statistic of Chen and Qin (2010) as above. It can be shown that
this vector-based test statistic will be powerless since the transformed random vectors will
indeed have a zero mean vector.
By contrast, we propose a simple approach to test hypothesis (1) that overcomes theoretical
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problems. In this direction, let Pc = Ic − Jc/c where Is is the identity matrix of size s and
Js is the s× s matrix of ones, and let tr(A) denote the trace operator of the matrix A. Note
that Pc is a symmetric and idempotent (P
2
c = Pc) matrix such that tr(M
TMPc) = 0 if and
only if H0 in (1) holds. Since the Frobenious norm, tr(M
TMPc), measures deviations from
H0, it seems meaningful to develop a test statistic based on the unbiased estimator of this
norm,
1
N(N − 1)
∑
i 6=j
tr(XTi XjPc).
Under rather weak conditions about the dependence structure of the row and column vari-
ables, outlined in Section 2.2, this estimator asymptotically follows a normal distribution,
and hence, the critical region of the test statistic can be defined under H0.
The main contribution of this paper is that we extend this idea to test more complicated
hypotheses than hypothesis (1) for the mean matrix. In particular, we consider the hypothesis
H0 : M = [µ11
T
c1
,µ21
T
c2
, . . . ,µg1
T
cg ] vs H1 : M 6= [µ11Tc1 ,µ21Tc2 , . . . ,µg1Tcg ], (2)
where c1, . . . , cg are positive integers such that
∑g
q=1 cq = c with at least one cq > 2 and
µ1, . . . ,µg are g unknown r-variate parameter vectors. H0 in (2) states that in each one of
the given g column groups there is no column effect upon the mean of the row variables.
Since g is known but arbitrary, the proposed testing procedure is not limited by the number
of column groups or the group size under consideration. For example, hypothesis (1) is a
special case of hypothesis (2) with g = 1 and c1 = c while the hypothesis that two column
variables, say the first two, have a common mean vector is obtained by setting g = c − 1,
c1 = 2 and c2, . . . , cg = 1. Similarly to testing hypothesis (1), the proposed test statistic will
be based on an asymptotic argument via a pivotal quantity that is the unbiased estimator
of the distance of the mean matrix from H0 in (2).
This article is structured as follows. In Section 2, we introduce the high-dimensional
working framework and we construct the test statistic for testing hypothesis (2). Also, we
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discuss the asymptotic power of the proposed test, we argue that the required assumptions
that make the high-dimensional setting manageable are weak, and we provide guidelines to
ease the computational task whenever straightforward calculation of the test statistic is time-
consuming. In Section 3, we examine the performance of the proposed testing methodology in
finite samples using simulations. In Section 4, we apply the proposed testing methodology to
two microarrays studies where gene expression levels are measured in different tissue samples
(Sottoriva et al., 2013; Zahn et al., 2007). In Section 5, we summarize the main findings of
our research and discuss how this method can be extended to test additional hypotheses for
the mean matrix. The Appendix contains technical details.
2. Test Statistics for the Mean Matrix
As the generative process for transposable data, consider a matrix-valued extension of the
nonparametric model for vectors considered in Bai and Saranadasa (1996) and Chen and
Qin (2010)
Xi = Wi + M (3)
for i = 1, . . . , N , where
(1) M = E[Xi] is the r × c mean matrix,
(2) Wi is an r× c matrix of random variables such that vec(Wi) = Σ1/2vec(Zi), and where
vec(A) denotes vectorization of the matrix A,
(3) Σ = Σ1/2Σ1/2 = cov[vec(Xi)] is an (rc)× (rc) positive-definite covariance matrix,
(4) Z1, . . . ,ZN are i.i.d. r × c random matrices and Ziab is the (a, b)-th element of Zi,
(5) E[Ziab] = 0, E[Z
2
iab] = 1, E[Z
4
iab] = 3 + B for a finite constant B > −2, E[Z8iab] <∞ and
for any positive integers l1, . . . , lq with
∑q
ν=1 lν 6 8
E[Z l1ia1b1Z
l2
ia2b2
. . . Z
lq
iaqbq
] = E[Z l1ia1b1 ]E[Z
l2
ia2b2
] . . .E[Z
lq
iaqbq
]
for (a1, b1) 6= (a2, b2) 6= · · · 6= (aq, bq).
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The matrix-variate normal distribution (Dawid, 1981; Gupta and Nagar, 2000), a common
and sensible choice for modeling transposable data, is a special case of model (3). To see
this, let Ziab be i.i.d. random variables from a standard normal distribution N(0, 1) and let
Σ = Σ2 ⊗Σ1, where Σ1 is the covariance matrix of the row variables, Σ2 is the covariance
matrix of the column variables and ⊗ denotes the Kronecker product operator applied to
matrices. However, we underline that model (3) is more general. It can handle departures
from the matrix-variate normal model by relaxing the normality and/or the covariance
structure assumption. First, the distribution of the “white-noise” random variables in Zi
remains unspecified. In fact, the white noise random variables do not need to be independent
or identically distributed. The latter holds because the results of this paper are not affected
even if the assumption of common fourth moments for the elements of Zi is dropped. Finally,
the dependence structure between and among the row and column variables is not limited
to a Kronecker product form.
To construct the test statistic for testing hypothesis (2), we need additional notation. Let
P{c1,c2,...,cg} = diag(Pc1 ,Pc2 , . . . ,Pcg) be the c × c block diagonal matrix where the positive
integers are defined by H0 in (2). For notational ease, suppress the index set in P{c1,c2,...,cg}
and write instead P. Further, note that P is a projection matrix as it is both idempotent
and symmetric. The key to our proposal is to observe that tr(MTMP) = 0 if and only if
H0 in (2) holds. To see this, note that tr(M
TMP) = tr(PMTMP) is the sum of squares of
the elements of MP, whose (a, b)-th element equals the difference between µab, the (a, b)-
th element of M, and µ¯
(k)
a , the average of the a-th row in the mean matrix when this is
restricted to the column group, say k, to which column b belongs under H0 in (2). Therefore,
it is sensible to consider the unbiased estimator of tr(MTMP)
GN =
1
N(N − 1)
∑
i 6=j
tr(XTi XjP),
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whose variance is
Var[GN ] =
2
N(N − 1)tr
(
[Σ(P⊗ Ir)]2
)
+
4
N
vec(MP)TΣvec(MP).
Next, we define the asymptotic framework needed to derive the limiting distribution of GN .
We handle the high-dimensional setting without specifying the limiting rate of the pairwise
ratios of the triplet (N, r, c). This is a pragmatic restriction in many applications, including
our motivating examples, where the number of row (genes) and/or column (multiple samples)
variables are not expected to increase proportionally to the sample size. Instead, we assume
that as N →∞ and rc = r(N)c(N)→∞, the following conditions hold:
tr
(
[Σ(P⊗ Ir)]4
)
= o
{
tr2
(
[Σ(P⊗ Ir)]2
)}
(4)
and
vec(MP)TΣvec(MP) = o
{
1
N
tr
(
[Σ(P⊗ Ir)]2
)}
(5)
or
1
N
tr
(
[Σ(P⊗ Ir)]2
)
= o
{
vec(MP)TΣvec(MP)
}
. (6)
The assumption rc → ∞ is quite flexible and it does not require r → ∞ and c → ∞
simultaneously. On the contrary, the number of row or column variables is allowed to be
fixed provided that the other dimension of the transposable data tends to ∞. Condition (4)
specifies the class of covariance matrices for Σ under consideration. In Section 2.2, we argue
that this class is quite large and thus, the proposed testing procedure is not seriously
restricted. At least one of the conditions (5) and (6) is needed to control the asymptotic
variance of GN and to derive the asymptotic distribution of GN , given in Theorem 1.
Theorem 1: Under the nonparametric model (3), condition (4) and either condition (5)
or condition (6)
GN − tr(MTMP)√
Var[GN ]
 N(0, 1)
where  denotes convergence in distribution as N → ∞ and rc = r(N)c(N) → ∞.
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Consequently, under H0 in (2),
GN√
2tr ([Σ(P⊗ Ir)]2) /[N(N − 1)]
 N(0, 1).
The final step to construct the test statistic is to estimate tr ([Σ(P⊗ Ir)]2) consistently. To do
this without estimating the high-dimensional covariance matrix Σ, note that tr ([Σ(P⊗ Ir)]2) =
tr(Ω2) where Ω = (P ⊗ Ir)Σ(P ⊗ Ir) is the positive semi-definite covariance matrix of
Yi = vec(XiP), and let
TN =
1
DN2
∑
i 6=j
(YTi Yj)
2 − 2 1
DN3
∑∗
i 6=j 6=k
YTi YjY
T
i Yk +
1
DN4
∑∗
i 6=j 6=k 6=l
YTi YjY
T
k Yl
where Dst = (s − t)!/s! and
∑∗ denotes summation over mutually exclusive indices. Since
tr(Ω4) = o
{
tr2(Ω2)
}
, E[TN ] = tr(Ω
2) and Var[TN ] = o{tr2(Ω2)}, it follows that TN is a
ratio-consistent estimator of tr(Ω2). Therefore, the proposed test rejects H0 in (2) with an
α significance level if and only if
G∗N =
GN√
2TN/[N(N − 1)]
> za,
where za is the upper α-quantile of N(0, 1).
To study some properties of G∗N , consider the transformation Xi 7−→ aAXi + C where
a 6= 0 ∈ <, A is an r× r orthogonal matrix and C is an r× c matrix of constants such that
CP = 0r×c, and where 0s×t denotes the zero matrix of size s× t. As desired, the test statistic
is invariant to (i) orthogonal rotations of the row variables (ii) to scalar multiplication and
(iii) to a location shift of the mean matrix under H0 in (2). In addition, (iii) also implies that
the nominal size of the test statistic is not affected by the magnitude of the true mean matrix
M given that this satisfies H0 in (2). Although the test statistic was derived for testing the
mean structure of row variables across groups of column variables, we emphasize that the
same procedure can be used to test the mean structure of column variables across groups
of row variables. For doing this, one needs to apply the transformation Xi 7−→ XTi prior to
calculating the test statistic.
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2.1 Asymptotic power
Investigation of the asymptotic power of the proposed test relies on Theorem 1. Under
condition (5), the leading order power is
βN = Φ
(
−za +N tr(M
TMP)√
2tr(Ω2)
)
,
where Φ is the cumulative distribution function of N(0, 1). The power of the proposed test
is bounded since
Φ
(
−za +N tr(M
TMP)√
2tr(Σ2)
)
6 βN 6 Φ
(
−za +N tr(M
TM)√
2tr(Ω2)
)
,
and thus a sufficient condition for the proposed test to have non-trivial power is
lim
N,(rc)→∞
N
tr(MTMP)√
2tr(Σ2)
> 0.
To gain insight into the asymptotic power, assume independent row and column variables
and no row-effect in the mean structure, that is µab = µb where µab is the (a, b)-th element
of M. Then
N
tr(MTMP)√
2tr(Ω2)
= N
√
r
2(c− g)
g∑
k=1
ck∑
b=ck−1+1
(µb − µ¯(k))2,
where c0 = 0 and µ¯
(k) is the average of the mean of the row variable a in group k. Contrary
to univariate tests that require multiple testing correction, the asymptotic power of the
proposed test is an increasing function of the number of row variables r regardless of the
differences µb − µ¯(k). Thus, in high-dimensional settings it should be more beneficial to
utilize the global test proposed herein than to apply univariate tests, a speculation that was
empirically verified in simulations.
Under condition (6), similar conclusions can be drawn about the power of the test statistic
since the leading order power term becomes
βN = Φ
(
N
tr(MTMP)√
2tr(Ω2)
)
.
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2.2 Class of covariance matrices under consideration
Condition (4) defines the class of covariance matrices to which the proposed test is applicable.
To provide a few examples of this class, note that if tr(Σ4) = o
{
tr2(Σ2)
}
then condition (4)
holds. This includes the cases where Σ has bounded eigenvalues or it has a few eigenvalues
that diverge slowly to infinity (Chen and Qin, 2010) or when Σ implies a (banded) first
order autoregressive correlation pattern such that the rc variances are bounded away from 0
or ∞ (Chen et al., 2010). In addition, condition (4) is also satisfied when Σ is a compound
symmetry correlation matrix, i.e. Σ = ρIrc + (1− ρ)Jrc for −1/(rc− 1) < ρ 6 1. As before,
this result extends to the case where Σ satisfies a compound symmetry correlation pattern
and the variances are bounded away from 0 and ∞.
Because of the popularity of the matrix-variate normal distribution in modelling trans-
posable data, we study the implications of condition (4) when Σ = Σ2 ⊗ Σ1. In this case,
condition (4) becomes
tr
[
(PΣ2)
4
]
tr(Σ41) = o
{
tr2
[
(PΣ2)
2
]
tr2(Σ21)
}
,
which is met if, for example, Σ1 and Σ2 satisfy any of the covariance structures mentioned
above. Therefore, a Kronecker product dependence pattern for Σ does not seem to impose
restrictions on applying the proposed testing procedure.
When the number of row or column variables is fixed, the class of covariance matrices
for Σ might be slightly restricted depending on which set of variables (row or column) is
fixed. To see this, suppose that Σ = Σ2 ⊗ Σ1. If the number of column variables is fixed,
then condition (4) becomes tr(Σ41) = o
{
tr2(Σ21)
}
, and it follows that Σ1 cannot satisfy a
compound symmetry correlation structure. However, if the number of row variables is fixed,
then condition (4) becomes tr [(PΣ2)
4] = o {tr2 [(PΣ2)2]}, and therefore the compound
symmetry correlation structure is an acceptable dependence structure for Σ2.
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2.3 Computational details
The proposed testing procedure does not require explicit estimation of the high dimensional
matrix parameters M or Σ but only of tr(Ω2). This is computed efficiently through TN by
applying the transformation Xi 7−→ XiP. Although the provided form of TN is computa-
tionally intensive for large N , the task of calculating TN can be greatly simplified as shown
in Himeno and Yamada (2012).
One way to calculate GN is to apply first the transformation Xi 7−→ XiP and then use
the corresponding expression given in the Appendix. However, if c >> r, then it seems more
sensible to ignore the transformation step and calculate GN by applying the circular property
of the trace operator, i.e. writing tr(XTi XjP) as tr(XjPX
T
i ).
To this end, note that column groups of size one do not contribute to the test statistic,
meaning that the value of G∗N does not change if column groups of size one (ck = 1) are
ignored. This is not surprising since no mean comparisons are performed therein. Hence,
these column variables should be removed prior to calculating the test statistic.
3. Simulation Studies
We investigated the nominal size and the power of the proposed testing procedure using
simulations. The simulated random matrices X1, . . . ,XN satisfied model (3). To study the
nonparametric nature of the proposed methodology, three distributional scenarios were con-
sidered for the elements of Zi:
Scenario 1: A normality scenario, in which Ziab
i.i.d∼ N(0, 1).
Scenario 2: A centralized gamma distributed scenario, in which Ziab = (Z
∗
iab − 8)/4 and
Z∗iab
i.i.d∼ Gamma(4, 0.5).
Scenario 3: A mixture of Scenarios 1 and 2, in which the random variables in the upper
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half of Zi are distributed as in Scenario 1, while the remaining random variables are
distributed as in Scenario 2.
Conditional on N , M, Σ and the distributional scenario, we draw 1000 replicates while keep-
ing the significance level fixed at 5%. For each competing testing procedure, we calculated the
empirical size as the proportion of rejections when M = 0r×c and the empirical power as the
proportion of rejections when M 6= 0r×c as defined in Sections 3.1 and 3.3. To distinguish
the test statistics of the proposed methodology used in the simulations, we denoted by
H{c1,c2,...,cg} the test statistic G
∗
N of the proposed methodology based on P{c1,c2,...,cg}. Further,
we let [t] denote the integer part of t ∈ <.
3.1 Comparison with univariate tests that require multiple testing correction
For testing the hypothesis of no column effect in the mean matrix, i.e. testing hypothesis (1),
we compared the proposed testing procedure, evaluated using H{c}, to univariate tests that
require multiple testing correction.
First, we considered the ANOVA test of no group effect and the Kruskal-Wallis test.
These tests were applied sequentially to each of the r row variables and the resulting p-
values were adjusted using the false discovery rate (FDR) correction and the Bonferroni
(BON) correction. To ensure a fair comparison, no dependence structure (Σ = Irc) was
assumed between and among the row and column variables. To evaluate the empirical power
of the three competing testing procedures, we used M = [0r×7, tJr×3] where Jk×l denotes
the k × l matrix of ones. The constant t was selected such that tr(MTM)/√r(c− 1) = 0.1,
i.e. by fixing the quantity that determines the upper bound of the asymptotic power of
any test statistic of the proposed methodology equal to 0.1. Table 1 displays the results
under Scenario 3 - similar patterns were observed under the other two scenarios. Unlike the
Kruskal-Wallis test which seemed to be conservative unless N = 100, the empirical sizes for
H{c} and the ANOVA test appeared to be a good approximation of the nominal size even for
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N = 10. Despite the conservativeness of the proposed test for N = 10, it was always more
powerful than the ANOVA and the Kruskal-Wallis test. In fact, the power of the proposed
test increased as r increased while that of the competing testing procedures decreased. This
trend validates our speculations about the power of the proposed test over univariate tests
in high-dimensional settings.
[Table 1 about here.]
Next, note that if the column variables are independent, then the columns of the N random
matrices can be classified in c groups, one group for each column variable, such that each
group contains N independent r-variate random vectors. In this case, an alternative approach
to test hypothesis (1) is to apply the two-sample mean test proposed by Chen and Qin
(2010) to all possible pairs of groups, and then adjust the resulting p-values for multiple
testing. To satisfy the required assumptions of the Chen-Qin test, Σ was set equal to a block
diagonal matrix with c blocks. Each block of Σ satisfied a first-order autoregressive form
({ρ|a−b|}16a,b6r) where ρ = 0.5 in the first c/2 blocks and ρ = 0.4 elsewhere. Table 2 shows
the empirical sizes of the two competing testing procedures across the three distributional
scenarios. The Chen-Qin test appeared to have a highly inflated empirical size even when
r = 500 while the proposed test seemed to preserve the nominal size. For this reason, we did
not proceed to power investigations.
[Table 2 about here.]
3.2 Nominal size
Using H{c}, H{[0.7c],[0.3c]} and H{[0.5c],[0.2c],[0.3c]}, we examined in greater detail the size of the
proposed methodology. For the dependence structure, we assumed that Σ = Σ2⊗Σ1 where
Σ1 = {0.85|a−b|}16a,b6r and Σ2 = 0.5(Ic + Jc). We also employed an exchangeable form for
Σ but the simulation results were similar and so we do not present them here. To reflect
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practical situations where the dimension of the mean vector is at least equal to the sample size
(N) and the number of row variables (r) is greater or equal to the number of column variables
(c), we set N = 10, 30, 50, 100, r = 100, 500 and c = 10, 100. Also, we covered the case where
the number of row variables is much smaller than the number of column variables by using
r = 10 and c = 100, 500. Table 3 contains the empirical sizes under Scenario 3. Again,
similar results were observed for the other two distributional scenarios, a fact that validates
empirically the non-parametric nature of the methodology. The discrepancy between the
empirical and nominal size was small for all three test statistics. As desired, this confirms
the robustness of the testing procedure to the number of groups and to the group sizes.
[Table 3 about here.]
3.3 Power considerations
Using H{c}, H{[0.6c],[0.4c]} and H{[0.4c],[0.2c],[0.4c]}, we evaluated the empirical power of the pro-
posed methodology under two different configurations of the mean matrix. First, we defined
M = [0Tr×[0.7c],µ1
T
[0.3c]] and similarly to Chen and Qin (2010), we let µ contain a varying
proportion (0%, 25%, 50%, 75%, 95% and 99%) of non-zero elements. At each proportion
level, we employed two types of allocations for the non-zero elements: (i) equal allocation
and (ii) linearly increasing allocation where two nonzero-elements of µ satisfy µl1 < µl2 if
and only if l1 < l2. We set r = 100, c = 10 and we used a Kronecker product form for Σ
with Σ1 = {0.8|a−b|}16a,b6r and Σ2 = 0.5(Ic + Jc). To make the results comparable across
the different proportion levels, the non-zero elements of µ were defined in such a way that
tr(MTM)√
tr(Σ21)tr(Σ
2
2)
= 0.1.
Table 4 displays the simulation results for H{6,4}. Similar trends occurred for H{4,2,4} but not
for H{10}, which was extremely powerful in these settings. This indicates that as we move
away from H0, the power of the proposed methodology increases. Conditional on the sample
size, the empirical power was similar across the three distributional scenario and it did not
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depend on the type of allocation or the proportion level. The proposed testing procedure
was powerful to the sparsity scenarios considered and their empirical power approached 1.00
as N increased.
[Table 4 about here.]
The second configuration of M we employed involved a multiplicative mean vectors scenario
in which M = [µ1T[0.9c], tµ1
T
[0.1c]] with t 6= 0 ∈ <. In this simulation scheme, the following
settings were used: µ = 1r, t = 1.15, Σ1 = {0.85|a−b|}16a,b6r and Σ2 = 0.5(Ic + Jc) for
r = 100, 500 and c = 10, 100. Table 5 displays the simulation results based on H{c} across
the three distributional scenarios. The tests based on H{[0.6c],[0.4c]} and H{[0.4c],[0.2c],[0.4c]} were
more powerful and hence we do not show these results. In addition to the desired trends
mentioned above, the test appeared to be consistent as the number of row and/or column
variables increased.
[Table 5 about here.]
4. Two Examples
We applied our proposed testing methodology to two datasets.
4.1 The glioblastoma dataset
The glioblastoma (GB) dataset describes an experimental study designed to investigate the
heterogeneity of GB (Sottoriva et al., 2013). For each of the patients (N = 8) included in
the study, mRNA samples were extracted from the tumor mass, the tumor margin and the
subventricular zone. From the tumor mass, 5 RNA samples were collected from different
fragments such that earlier fragments were closer to the tumor margin and later fragments
closer to the subventricular zone. Gene expression levels were then measured from the mRNA
samples using microarrays. The data for each subject were organized in a matrix where the
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row variables (r = 16810) correspond to genes and the column variables (c = 7) to the
margin, the subventricular zone and the five tumor fragments ordered in the spatial order
described above.
A biological objective in this study was to assess whether for each gene the mean expression
level was constant across the tumor fragments, i.e., testing the hypothesis H0 : M =
[µ1,µ2,µ31
T
5 ], where µ1,µ2 and µ3 are unknown r-variate vectors. The test statistic equals
−0.282 (p-value= 0.611), meaning that we fail to reject the null hypothesis. Since we rejected
any hypothesis that implies a simpler mean structure than the one tested (results not shown),
it seems sensible to assume that the mean vectors of the margin, subventricular zone and
tumor fragments are not equal.
We investigated further the mean gene expression levels using Gene Ontology (GO) terms.
The GO terms classify genes into groups such that the genes within a group are involved
in the same biological process and therefore, similar behavior in the gene expression levels
might be expected. From the 1316 gene groups in the GB dataset, we selected 166 groups
that had more than 10 genes in order to be closer to the high-dimensional assumptions. To
determine the mean structure in each of these groups, we employed the following stepwise
strategy. First we tested the assumption of no differentially expressed genes in each group,
that is the hypothesis of a constant mean vector across the margin, the subventricular zone
and the tumor fragments. For the groups that we rejected the null hypothesis, we tested
the hypothesis of a common mean vector between the subventricular zone and the tumor
fragments. The gene groups where the null hypothesis was rejected were then tested for
the hypothesis of a common mean vector between the margin and the subventricular zone.
Finally, the groups that rejected all the null hypotheses were tested for the hypothesis of a
common mean vector between the margin and the tumor fragments. Note that at each step
of this procedure, we applied an FDR correction. In this way, we identified 5 gene groups
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in which each gene had a constant mean expression level across the different tissue samples,
102 groups in which each gene had the same mean expression level in the subventricular zone
and in the tumor fragments, 25 groups in which each gene had the same mean expression
level in the margin and the subventricular zone, and 34 groups that satisfied the global mean
relationship described in the previous paragraph.
4.2 The mouse aging dataset
The atlas of gene expression in the mouse aging data (Zahn et al., 2007) contains mouse
mRNA gene expression levels measured in different tissues. For each mouse (N = 40),
mRNA expression levels were extracted for r = 8932 genes from up to 16 tissues. Here,
we considered c = 9 tissues (adrenal glands, cerebrum, hippocampus, kidney, lung, muscle,
spinal cord, spleen and thymus) for which mRNA gene expression levels were available for
all the mice.
Our goal was to determine if there exist groups of tissues that have similar gene expression
levels. To explore this, first we tested the hypothesis of no tissue effect which was rejected
since G∗N = 481.28 (p-value< 0.001). This is not surprising since we do not expect con-
servation of the gene expression across the tissues. However, a small subset of genes called
‘housekeeping’ genes are presumably expressed at a relatively constant level across many
or all known experimental conditions. Hence, an interesting question is whether they have
constant gene expression levels across tissues. To do this, we created a list of 22 housekeeping
genes by considering 8 genes that are commonly classified as housekeeping genes in the
literature (de Jonge et al., 2007) and 14 genes that were suggested as housekeeping genes
in de Jonge et al. (2007). We rejected the hypothesis of no tissue effect upon the mean
expression level of the housekeeping genes (G∗N = 382.93 and p-value< 0.001). Hence, the
expression levels of the housekeeping genes in mice should not be considered to be constant
across different tissues in mice.
Testing the Mean Matrix in High-Dimensional Transposable Data 17
5. Discussion
We proposed a novel non-parametric procedure to test the mean matrix in high-dimensional
transposable data. In particular, our methodology can determine whether in each of the given
groups of column variables the mean of every row variable remains constant. Of course, the
role of the row and column variables is interchangeable in transposable data and hence the
proposed tests can be applied to check the effect of the row variables upon the mean vector of
the column variables. The simulation studies verified the robustness of the proposed testing
procedure to the number of row or column groups, to the size of each group, to the number
of column and row variables relative to the sample size, and to the underlying dependence
structure between and among the row and column variables. Compared to univariate testing
procedures that preserve the nominal size, the proposed test was substantially more powerful.
In a sense, we developed a theoretically sound non-parametric testing procedure that extends
the application of ANOVA based tests to high-dimensional matrix-valued random variables
by making mild assumptions about the dependence structure. A practical advantage of the
proposed test is the computationally simplicity because the cumbersome task of estimating
high-dimensional matrix parameters is avoided.
We emphasize that a critical point in our proposal is the choice of the projection matrix P.
Although Theorem 1 holds for any projection matrix, say P∗, to avoid trivial power under
certain alternatives it is essential to require that MP∗ = 0r×c if and only if the corresponding
null hypothesis is true. To illustrate this, note that an alternative way to test hypothesis (1)
is to consider the projection matrix P∗ = Jc/c (instead of Pc = Ic − Jc/c). It can be shown
that the asymptotic power of the resulting test statistic is trivial if, for example, c is even
and the mean vector is µ for the odd columns of M and −µ for the even columns. Thus
attention is required when projection matrices other than the suggested ones are used.
It is important to note that it might be possible to modify the proposed methodology in
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such a way that the same type of test statistic can be used to test hypotheses other than
hypothesis (2). For example, consider testing the hypothesis of a known r × c matrix of
constants M0, i.e. H0 : M = M0. To do this, we can center the data by subtracting M0 and
then employ the test statistic G∗N calculated using P = Jc/c. Another example is testing the
hypothesis H0 : µ1 − µ2 = µ0, where µ1 and µ2 are the unknown r-variate mean vectors
of the first and second column variable respectively, and µ0 is an r-variate vector of known
constants. To test this hypothesis, one needs to subtract µ0 from the first column of each
data matrix and then test hypothesis (2) with g = 2, c1 = 2 and c2 = . . . = cg = 1 using
the transformed data. In a similar way, the proposed method can be extended to test known
differences in the mean vectors of two or more column groups. In future work, we aim to
develop test statistics for hypotheses that cannot be directly handled by the proposed testing
methodology, e.g. the hypothesis of a mean-restricted matrix (Allen and Tibshirani, 2010),
that is M = µ1Tc + ν
T1r where µ is an r-variate vector of constants and ν is a c-variate
vector of constants.
From a practical point of view, we expect that the experimental design will dictate the null
hypothesis of interest about the mean-relationship between the row and column variables,
as was the case with the glioblastoma dataset. In applications like the mouse aging dataset,
where it is not clear which column groups should be formed under the null hypothesis, we
suggest the following simple strategy. First, test whether there is no column (or row) effect
upon the mean of the row (column) variables. If we fail to reject this hypothesis, assume
that the mean of the row (column) variables is independent of the column (row) variables.
Otherwise, perform the test that two column (row) variables have the same mean vector for
all pairs of column (row) variables, and then apply a multiple testing correction. If all the
adjusted p-values are very small, then assume an unstructured mean matrix M. Otherwise,
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record the column (row) pairs for which the adjusted p-values< 0.05, form g column (row)
groups and test hypothesis (2) as defined by the g groups.
We plan to include our testing methodology in an R package but currently R functions are
available upon request.
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Appendix
Sketch of the proof of Theorem 1
Without loss of generality, let P be an idempotent and symmetric matrix and define Yi =
vec(XiP) for all i, where E[Yi] = vec(MP) and cov[Yi] = Ω = (P⊗ Ir)Σ(P⊗ Ir). Rewrite
relations (4), (5) and (6) as tr(Ω4) = o
{
tr2(Ω2)
}
, vec(M)TΩvec(M) = o
{
tr(Ω2)/N
}
and
tr(Ω2)/N = o
{
vec(M)TΩvec(M)
}
respectively, and note that
GN =
1
N(N − 1)
∑
i 6=j
tr(XTi XjP) =
1
N(N − 1)
∑
i 6=j
YTi Yj.
With this parameterization, the asymptotic distribution of (GN −E[GN ])/
√
Var[GN ] can be
derived in a similar fashion as in the proof of Theorem 1 in Chen and Qin (2010).
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Table 1
Empirical size and power of H{10}, ANOVA and Kruskal-Wallis test at 5% significance.
ANOVA Kruskal-Wallis
H{10} FDR BON FDR BON
r N Power Size Power Size Power Size Power Size Power Size
100 10 0.138 0.063 0.051 0.047 0.051 0.046 0.013 0.014 0.013 0.014
30 0.412 0.057 0.091 0.045 0.088 0.045 0.062 0.040 0.060 0.039
50 0.756 0.053 0.136 0.045 0.125 0.044 0.115 0.043 0.112 0.043
100 0.997 0.044 0.319 0.047 0.294 0.045 0.317 0.048 0.285 0.047
500 10 0.186 0.063 0.075 0.066 0.075 0.066 0.011 0.008 0.011 0.008
30 0.703 0.039 0.096 0.060 0.094 0.059 0.051 0.033 0.047 0.033
50 0.974 0.040 0.102 0.042 0.093 0.040 0.082 0.026 0.077 0.026
100 1.000 0.051 0.261 0.054 0.244 0.053 0.253 0.048 0.233 0.047
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Table 2
Empirical size of H{10} and the Chen-Qin test at 5% significance.
Scenario 1 Scenario 2 Scenario 3
r N H{10} Chen-Qin H{10} Chen-Qin H{10} Chen-Qin
100 10 0.066 0.179 0.048 0.179 0.065 0.173
20 0.058 0.144 0.050 0.150 0.059 0.144
30 0.069 0.147 0.059 0.157 0.056 0.158
50 0.046 0.142 0.057 0.126 0.063 0.169
500 10 0.059 0.114 0.045 0.104 0.057 0.097
20 0.046 0.115 0.051 0.090 0.054 0.091
30 0.046 0.084 0.054 0.081 0.040 0.078
50 0.050 0.091 0.054 0.090 0.050 0.077
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Table 3
Empirical size of the proposed methodology under the mixture distributional scenario at 5% significance.
N r H{c} H{[0.7c],[0.3c]} H{[0.5c],[0.2c],[0.3c]}
c 10 100 10 100 10 100
10 100 0.064 0.056 0.059 0.056 0.057 0.058
500 0.068 0.067 0.068 0.067 0.060 0.067
30 100 0.063 0.053 0.061 0.050 0.060 0.049
500 0.049 0.054 0.053 0.048 0.049 0.049
50 100 0.058 0.046 0.059 0.048 0.064 0.048
500 0.060 0.058 0.066 0.062 0.054 0.059
100 100 0.047 0.055 0.050 0.053 0.057 0.058
500 0.047 0.048 0.049 0.040 0.048 0.044
c 100 500 100 500 100 500
10 10 0.055 0.065 0.052 0.067 0.052 0.068
30 10 0.061 0.059 0.057 0.058 0.057 0.055
50 10 0.054 0.053 0.057 0.053 0.056 0.054
100 10 0.062 0.045 0.065 0.045 0.058 0.045
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Table 4
Empirical power of H{6,4} for the sparsity scenario with r = 100 at 5% significance.
Equal Allocation Increasing Allocation
N #{µ1l = µ2l} Scenario 1 Scenario 2 Scenario 3 Scenario 1 Scenario 2 Scenario 3
10 99% 0.194 0.213 0.173 0.194 0.213 0.173
95% 0.175 0.207 0.164 0.172 0.213 0.163
75% 0.166 0.204 0.171 0.168 0.205 0.173
50% 0.174 0.211 0.169 0.172 0.207 0.169
25% 0.173 0.203 0.170 0.169 0.203 0.168
0% 0.167 0.201 0.165 0.164 0.199 0.166
30 99% 0.605 0.609 0.606 0.605 0.609 0.606
95% 0.626 0.582 0.605 0.623 0.589 0.605
75% 0.632 0.634 0.635 0.637 0.637 0.642
50% 0.643 0.646 0.649 0.651 0.648 0.650
25% 0.645 0.647 0.654 0.647 0.645 0.653
0% 0.658 0.644 0.663 0.662 0.643 0.666
50 99% 0.903 0.868 0.882 0.903 0.868 0.882
75% 0.896 0.897 0.899 0.904 0.898 0.896
50% 0.938 0.936 0.934 0.947 0.941 0.936
25% 0.962 0.955 0.949 0.965 0.958 0.954
5% 0.964 0.959 0.954 0.967 0.964 0.958
0% 0.965 0.966 0.961 0.969 0.967 0.963
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Table 5
Empirical power of H{c} for the multiplicity scenario at 5% significance.
c 10 100 10 100 10 100
N r Scenario 1 Scenario 2 Scenario 3
10 100 0.097 0.317 0.128 0.282 0.103 0.303
500 0.210 0.778 0.207 0.813 0.206 0.781
30 100 0.291 0.975 0.313 0.964 0.294 0.966
500 0.809 1.000 0.782 1.000 0.790 1.000
50 100 0.590 1.000 0.551 1.000 0.576 1.000
500 0.997 1.000 0.992 1.000 0.998 1.000
